JP Morgan Chase’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150,000
Closed -$1.51M 7236
2021
Q4
$1.51M Hold
150,000
﹤0.01% 4061
2021
Q3
$1.49M Hold
150,000
﹤0.01% 4004
2021
Q2
$1.51M Hold
150,000
﹤0.01% 3990
2021
Q1
$1.5M Buy
+150,000
New +$1.53M ﹤0.01% 3916

Other funds holding SHACU

JP Morgan Chase's SHACU Position: Q1 2022 in Review

JP Morgan Chase sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q1 2022, closing a stake of 150,000 shares — an estimated $1.51M sold.

JP Morgan Chase first reported a position in SHACU in Q1 2021 and held it in 4 quarters. The position peaked at $1.51M in Q2 2021. 18 funds tracked by Wall St. Rank hold SHACU as of Q1 2022.

  • JP Morgan Chase reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Chase sold 150,000 SCP & CO Healthcare Acquisition Company Unit shares in Q1 2022, an estimated $1.51M.
  • JP Morgan Chase first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 4 quarters.
  • JP Morgan Chase's SCP & CO Healthcare Acquisition Company Unit position peaked at $1.51M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q1 2022.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.